Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

NEXGEL, INC. (NXGLW)

  • SEC News
  • Aug. 20, 2026, 13:39 UTC
  • 0
  • 0 comments

New Form S-1 - NEXGEL, INC. <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001493152-26-039421 <b>Size:</b> 414 KB

Comment Full text

PENTAIR PLC (PNR)

  • Business News
  • Aug. 20, 2026, 13:39 UTC
  • 0
  • 1 comments

Pentair plc (PNR) Notice of October 2, 2026 Application Deadline for Class Action Lawsuit

Market reaction Comment Full text

BOSTON SCIENTIFIC CORPORATION

  • Business News
  • Aug. 20, 2026, 13:38 UTC
  • 0
  • 1 comments

Clinical trial NCT06773845 updates: 1. completion date: 2029-12-31 → 2030-12-31 2. primary completion date: 2027-12-31 → 2028-12-31

Market reaction Comment Full text

NORTHWEST BIOTHERAPEUTICS INC

  • Business News
  • Aug. 20, 2026, 13:38 UTC
  • 0
  • 1 comments

Clinical trial NCT07072598 updates: 1. status: RECRUITING → WITHDRAWN 2. start date: 2026-04-25 → 2026-04-01 3. enrollment: 80 → 0 participants 4. enrollment type: ESTIMATED → ACTUAL

Market reaction Comment Full text

ASTRAZENECA PLC (AZN)

  • Business News
  • Aug. 20, 2026, 13:38 UTC
  • 0
  • 1 comments

Clinical trial NCT06675552 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 438 → 338 participants 3. enrollment type: ESTIMATED → ACTUAL

Market reaction Comment Full text

INTEGRATIVE HEALTH TECHNOLOGIES, INC. (IHTI)

  • Business News
  • Aug. 20, 2026, 13:38 UTC
  • 0
  • 1 comments

Clinical trial NCT06052631: start date: 2026-08-24 → 2026-08-25.

Market reaction Comment Full text

BECTON DICKINSON & CO (BDX)

  • Business News
  • Aug. 20, 2026, 13:38 UTC
  • 0
  • 1 comments

Clinical trial NCT03911700 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2031-12-01 → 2031-08-01 3. primary completion date: 2029-12-01 → 2028-08-01 4. enrollment type: ESTIMATED → ACTUAL

Market reaction Comment Full text

NORTHWEST BIOTHERAPEUTICS INC

  • Business News
  • Aug. 20, 2026, 13:38 UTC
  • 0
  • 1 comments

Clinical trial NCT06511505 updates: 1. completion date: 2027-03-01 → 2028-09-01 2. primary completion date: 2026-09-01 → 2027-09-01

Market reaction Comment Full text

MERCK & CO., INC. (MRK)

  • Business News
  • Aug. 20, 2026, 13:38 UTC
  • 0
  • 1 comments

Clinical trial NCT05899049 updates: 1. completion date: 2027-06-07 → 2027-04-22 2. primary completion date: 2027-06-07 → 2026-02-04 3. enrollment: 249 → 251 participants 4. enrollment type: ESTIMATED → ACTUAL

Market reaction Comment Full text

BAYER A.G. (BAYRY)

  • Business News
  • Aug. 20, 2026, 13:38 UTC
  • 0
  • 1 comments

Clinical trial NCT05457283 updates: 1. completion date: 2028-12-28 → 2028-11-07 2. primary completion date: 2028-11-28 → 2028-10-08

Market reaction Comment Full text

BAYER A.G. (BAYRY)

  • Business News
  • Aug. 20, 2026, 13:38 UTC
  • 0
  • 1 comments

Clinical trial NCT01065454: status: COMPLETED → TERMINATED.

Market reaction Comment Full text

MERCK & CO., INC. (MRK)

  • Business News
  • Aug. 20, 2026, 13:38 UTC
  • 0
  • 1 comments

Clinical trial NCT05468697 updates: 1. completion date: 2026-09-22 → 2026-10-22 2. primary completion date: 2026-09-22 → 2026-10-22

Market reaction Comment Full text

BRISTOL MYERS SQUIBB CO (BMY)

  • Business News
  • Aug. 20, 2026, 13:38 UTC
  • 0
  • 1 comments

Clinical trial NCT06756308 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 25 → 2 participants 3. enrollment type: ESTIMATED → ACTUAL

Market reaction Comment Full text

LANTHEUS HOLDINGS, INC. (LNTH)

  • Business News
  • Aug. 20, 2026, 13:38 UTC
  • 0
  • 1 comments

Clinical trial NCT05394259 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 36 → 20 participants 3. enrollment type: ESTIMATED → ACTUAL

Market reaction Comment Full text

COLGATE PALMOLIVE CO (CL)

  • Business News
  • Aug. 20, 2026, 13:38 UTC
  • 2
  • 1 comments

Clinical trial NCT07377344 updates: 1. start date: 2026-06-01 → 2026-09-30 2. completion date: 2028-06-01 → 2028-12-31 3. primary completion date: 2028-06-01 → 2028-09-30

Market reaction Comment Full text
  • Previous
  • 941
  • 942
  • 943
  • 944
  • 945
  • Next

Search

News categories

  • Technical Exchange News(14604)
  • Event(6229)
  • SEC News(385338)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(235120)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin